| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/08/2001 | DE19942624A1 Verfahren zur Herstellung von zyklischen Peptidomimetika A process for preparing cyclic peptidomimetics |
| 03/08/2001 | CA2382499A1 Method for coupling molecules |
| 03/08/2001 | CA2381713A1 Methods and compositions for reducing serum phosphate levels |
| 03/07/2001 | EP1080370A1 Identification of broadly reactive dr restricted epitopes |
| 03/07/2001 | EP1080080A1 Novel therapeutic agents that modulate neurokinin receptors |
| 03/07/2001 | EP1079859A1 Bifunctional molecules and therapies based thereon |
| 03/07/2001 | EP1079846A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 03/07/2001 | EP1079692A1 Biocontrol agent and pesticide |
| 03/07/2001 | CN1286264A Action of proinsulin associated peptide on dopamine transporter and its application in treating correlative diseases |
| 03/06/2001 | US6197946 Nucleotide sequences coding hybrid albumin polypeptide; for production of heterologous polypeptide in hybrid animals |
| 03/06/2001 | US6197583 Therapeutic compounds |
| 03/06/2001 | US6197541 Nucleic acid which codes for mammalian receptor having seven transmembrane domains; drug screening of anticoagulants and wound healing agents; diagnosis of cardiovascular disorders; treatment of restenosis and unstable angina |
| 03/06/2001 | US6197536 Methodology to produce, and purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease |
| 03/06/2001 | US6197526 Polypeptides for binding human factor VIII and fragments of human factor VIII |
| 03/06/2001 | US6197506 Using substrate having over 100 different polynucleotides at density of over 50 different polynucleotides per square centimeter to generate hybridization patterns and distinguish between two nucleic acid samples; heredity; diagnosis |
| 03/06/2001 | CA2021379C Pentapeptide antibiotics derived from dalbaheptides |
| 03/01/2001 | WO2001014408A2 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013934A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | CA2382174A1 Method for coupling, in solution, a peptide with at least another compound and uses thereof |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376250A1 Peptide and peptide analogues for the treatment and prevention of diabetes |
| 02/28/2001 | EP1078072A1 New peptide fragments for protein purification |
| 02/28/2001 | EP1078002A1 Peptide antiangiogenic drugs |
| 02/28/2001 | EP1077998A1 Labelled glutamine and lysine analogues |
| 02/28/2001 | EP1077997A2 Inhibition of the binding of protein tyrosine phosphatase pest to domains of signalling proteins |
| 02/28/2001 | EP1077731A1 Intramolecularly-quenched near infrared fluorescent probes |
| 02/28/2001 | EP1077721A1 Prevention and treatment of hypergastrinemia |
| 02/28/2001 | CN1285514A Medicine box bof testing anti-hepatitis C virus antibody |
| 02/27/2001 | US6194544 Cyclic semi-random peptide libraries |
| 02/27/2001 | US6194386 Labelled peptide compounds |
| 02/27/2001 | US6194383 Homologous cyclic amino-acid sequences having different fatty acid residues synthesized by actinoplanes sp.; peptide antibiotics, lipopeptides a 1437, a-m, effective against grampositive bacteria and glycopeptide-resistant strains |
| 02/27/2001 | US6194380 Agents for promoting bone formation |
| 02/27/2001 | US6194195 Pure culture; for production of hypotensive agents and therapies for asthma, cerebral apoplexy, angina pectoris, acute renal failure, cardiac infarction, and cerebral vasospasm |
| 02/27/2001 | US6194143 Substrates for human cytomegalovirus protease |
| 02/27/2001 | US6193981 Methods and compositions for impairing multiplication of HIV-1 |
| 02/27/2001 | CA2101316C Gnrh analogs |
| 02/22/2001 | WO2001013114A1 Use of stabilised synthetic compounds in immunoassay |
| 02/22/2001 | WO2001013112A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/22/2001 | WO2001013110A2 Detection of isomerised epitopes in autoimmune diseases |
| 02/22/2001 | WO2001012668A1 Cathelicidin-derived peptides with broad spectrum antimicrobial activity |
| 02/22/2001 | WO2001012656A1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 02/22/2001 | WO2001012593A1 Arylsulfonanilide derivatives |
| 02/22/2001 | WO2001012233A2 Sustained release formulation of a peptide |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | CA2382205A1 Detection of isomerised epitopes in autoimmune diseases |
| 02/22/2001 | CA2382056A1 Peptide analogs as selective inhibitors of thrombin activation of protease activated receptor 1 |
| 02/22/2001 | CA2379647A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/21/2001 | EP1077218A2 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 02/21/2001 | EP1077217A2 Neuroactive peptides and their use |
| 02/21/2001 | EP1076666A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein |
| 02/21/2001 | EP1076565A1 Indolicidin analogs and methods of using same |
| 02/21/2001 | EP0948525B1 Cyclic peptide derivatives |
| 02/21/2001 | EP0725825B1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains |
| 02/20/2001 | US6191256 Recombinant factor VIII binding peptides |
| 02/20/2001 | US6191254 Of given amino acid sequences |
| 02/20/2001 | US6191115 Peptides and polypeptides |
| 02/20/2001 | US6191113 Peptide for inhibiting growth of smooth muscle cells |
| 02/20/2001 | US6191110 Promoting wound healing in mammals with peptides |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190641 Indocyanine dyes |
| 02/20/2001 | CA2225412C A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component |
| 02/20/2001 | CA2119651C Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 02/20/2001 | CA2076749C Vasoactive vasotocin derivatives |
| 02/15/2001 | WO2001010895A1 Streptogramin derivatives, production thereof and compositions containing the same |
| 02/15/2001 | WO2001010893A2 Il-16 antagonists |
| 02/15/2001 | WO2001010892A2 Peptide antagonists of factor viia |
| 02/15/2001 | WO2001010891A2 Il-16 antagonists |
| 02/15/2001 | WO2000069900A3 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 02/15/2001 | WO2000063235A3 Materials and methods useful for the control of insect larvae |
| 02/15/2001 | CA2380633A1 Peptide antagonists of factor viia |
| 02/14/2001 | EP1075490A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 02/14/2001 | EP1075270A1 Short peptides for treatment of neurological degenerative diseases |
| 02/14/2001 | EP0738280B1 Superactive vip antagonists |
| 02/14/2001 | CN1284086A Conjugates useful in treatment of prostate cancer |
| 02/14/2001 | CN1284084A Echinocandin derivatives, prepn. method and application as anti-fungal agents |
| 02/14/2001 | CN1283987A Skin and hair darkening compsn |
| 02/14/2001 | CN1061991C Schistosome vaccine peptide NO.3 |
| 02/14/2001 | CN1061990C Schistosome vaccine peptide No.1 |
| 02/13/2001 | US6187907 Conjugate of three crosslinked polypeptide chains containing tripeptide or hexapeptide repeat sequences aligned to form triple helix coil and ligand covalently attatched to template; modeling; drug screening |
| 02/13/2001 | US6187905 Peptide compound which inhibits viral proteinases; viricides for hepatitis c, hepatitis g, and human gb viruses |
| 02/13/2001 | US6187284 Reacting a peptide comprising a free thiol group with an 18 f-bound labelling reagent which also has a group that is reactive with thiols. |
| 02/13/2001 | CA2160486C Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/13/2001 | CA2021788C Cyclosporin derivatives |
| 02/08/2001 | WO2001009193A1 Chimeric polypeptides, method for production and uses thereof |
| 02/08/2001 | WO2001009191A1 Computational design methods for making molecular mimetics |
| 02/08/2001 | WO2001009188A1 Binding moieties for fibrin |
| 02/08/2001 | WO2001009173A2 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | WO2001009171A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |
| 02/08/2001 | WO2001009165A2 ACTIVATION OF PEPTIDE PRODRUGS BY hK2 |
| 02/08/2001 | WO2001008677A1 Methods of inhibiting osteoclast activity |
| 02/08/2001 | WO2001008636A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
| 02/08/2001 | WO2000066528A3 Quinones for treatment of diseases |
| 02/08/2001 | WO2000063247A3 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
| 02/08/2001 | CA2647796A1 Method of inhibiting osteoclast activity |
| 02/08/2001 | CA2388663A1 Use of quinic, shikimic acids and their derivatives for preparing mannose receptor ligands |
| 02/08/2001 | CA2380354A1 Novel tachykinin peptides, precursor peptides thereof and genes encoding the same |